Genetic screening with multi-omics analyses of matched PARP-sensitive and PARP-resistant mouse breast tumors with BRCA2 mutation identified PARG loss as a major mechanism of PARPi resistance [133]. The gene discussed is PARP1; the disease is breast neoplasm.